item management s discussion and analysis of financial condition and results of operations the following is a discussion of the financial condition and results of operations of the company for the three years ended december  it should be read in conjunction with the company s consolidated financial statements  the related notes thereto and other financial and operating information included in this form k 
overview integramed america  inc the company offers products and services to patients  providers  payors and drug manufacturers in the infertility industry 
the company provides comprehensive business services to a nationwide network of reproductive science centers 
there are currently six sites designated as reproductive science centers and one pharmaceutical subsidiary integramed pharmaceutical services  inc 
each reproductive science center consists of a location or locations where the company has a business services agreement with either a physician practice or a hospital 
the current reproductive science center network comprises seventeen locations in seven states and the district of columbia and forty physicians and phd scientists  including physicians and phd scientists employed and or contracted by the medical practices  as well as  physicians who have arrangements to utilize the company s facilities 
the company s strategy is to align information  technology and finance for the benefit of fertility patients  providers  payors and pharmaceutical manufacturers 
the primary elements of the company s strategy include i selling additional reproductive science center business service contracts  ii increasing revenues at reproductive science centers  iii increasing sales of pharmaceutical products and services  iv expanding clinical research opportunities  v increasing treatment financing offerings to patients thereby making treatment more accessible to patients who otherwise would not be able to pursue therapy  vi establishing internet based access to patient specific information on treatment process and outcomes  and vii pursuing other allied fertility related product or service offerings that leverage the company s installed base of operations 
during the first quarter of  the company completed an equity private placement of million with morgan stanley venture partners affiliates 
in september  the company obtained from fleet bank  na a million credit facility to fund acquisitions over approximately the next one to two years  to provide working capital  and to refinance its existing bank debt 
during  the company recorded restructuring and other charges of approximately million associated with its termination of its agreement with the reproductive science center of greater philadelphia  a single physician reproductive science center  effective july   and exclusive right impairment losses related to two other single physician reproductive science centers 
in addition  due to continued operating losses and the company s decision to focus exclusively on fertility services  the company sold the adult women s medical division awm division operations effective september  in  the company recorded an aggregate charge of approximately million related to the operating losses and the disposal of the awm division 
during  the company accelerated amortization of the right to manage fees for the kansas city and dallas reproductive science centers 
the medical practices served by the company are parties to managed care contracts 
approximately and of the company s revenues  net for the years ended december  and  respectively  were derived from revenues received by the medical practices from third party payors 
to date  the company has not been negatively impacted by existing trends related to managed care contracts 
as the company s fees for servicing such medical practices are based on revenues and or earnings of the respective medical practices  changes in managed care practices  including changes in covered procedures or reimbursement rates could adversely affect the company s fees in the future 
results of operations the following table shows the percentage of net revenue represented by various expenses and other income items reflected in the company s consolidated statement of operations for the years ended december   and revenues  net costs of services incurred on behalf of reproductive science centers employee compensation and related expenses direct materials occupancy costs depreciation other expenses total costs of services reproductive science centers contribution general and administrative expenses amortization of intangible assets interest income interest expense total other expenses restructuring and other charges income loss from continuing operations before income taxes provision for income taxes income loss from continuing operations a discontinued operations loss net income loss a excluding the effect of the restructuring and other charges in  income from continuing operations  as a percentage of net revenues would have been for the year ended december  calendar year compared to calendar year revenues  net for were approximately million as compared to approximately million for  an increase of million or 
the increase in revenues was approximately attributable to new business services agreements entered into during the second quarter of and attributable to same market growth offset by losses of revenue due to terminated business services contracts 
same market growth was principally achieved via new service offerings  the expansion of ancillary services  and increases in patient volume 
the aggregate increase in revenue was comprised of the following i an approximate million increase in reimbursed costs of services  and ii an approximate  increase in the company s business services fees derived from the managed medical practices net revenue and or earnings  and iii million from pharmaceutical sales 
total costs of services as a percentage of revenue increased by to in as compared to in employee compensation and related expenses  direct materials  depreciation and other expenses increased primarily due to factors attributed to increasing revenues 
these factors include infrastructure expansion for various reproductive science centers  including shady grove  bay area  and boston 
reproductive science centers contribution increased to million in as compared to million in due to the factors attributed to increasing revenues 
the reproductive science centers contribution margin decreased to of revenues in from in primarily due to reimbursed services  which do not provide a margin  accounting for a higher percent of revenues and new service offerings with a lower contribution margin 
general and administrative expenses for were approximately million as compared to approximately million in  an increase of  primarily due to increases in staffing  legal expenses  and expenses related to the implementation of the artworks system 
amortization of intangible assets was million in as compared to million in the majority of this increase is attributed to a one time charge of million associated with accelerated amortization of right to manage fees of the kansas city and dallas reproductive science centers 
interest income for decreased to  from  for  due to a lower invested cash balance 
interest expense for decreased to  from  in  primarily due to payoffs of notes payable to the physician practice at shady grove 
the provision for income taxes is primarily related to state taxes as the company has utilized available net operating loss carryforwards to eliminate any federal tax provision 
the provision for income taxes decreased for the year ending december  as compared to  due to a change in effective tax rates as a result of tax planning initiatives 
income from continuing operations  excluding restructuring and other charges  was approximately  in as compared to million for the decrease was primarily due to the approximate  increase in reproductive science center contribution and a  reduction in income tax expense  which was offset by an  increase in general and administrative expenses and a million increase in amortization of intangible assets 
calendar year compared to calendar year revenues  net for were approximately million as compared to approximately million for  an increase of million  or 
the increase in revenues  excluding revenues related to the philadelphia reproductive science center agreement which was terminated effective july  and including revenues related to the san diego reproductive science center agreement which was terminated effective september   was approximately attributable to new business services agreements entered into during the first quarter of and the second and third quarter of and approximately attributable to same market growth 
same market growth was principally achieved via new service offerings  the expansion of ancillary services  and increases in patient volume 
the aggregate increase in revenue was comprised of the following i an approximate million increase in reimbursed costs of services  and ii an approximate million increase in the company s business services fees derived from the managed medical practices net revenue and or earnings 
total costs of services as a percentage of revenue increased by to in as compared to in employee compensation and related expenses  direct materials  depreciation and other expenses as a percentage of revenue increased primarily due to the factors attributable to increasing revenues 
occupancy costs as a percentage of revenue decreased primarily due to the significant increase in revenues 
reproductive science centers contribution increased to million in as compared to million in due to the factors attributable to increasing revenues 
the reproductive science centers contribution margin decreased to of revenues  net in from in primarily due to reimbursed services accounting for a higher percent of revenues 
general and administrative expenses for were approximately million as compared to approximately million in  an increase of  primarily due to increases in staffing and travel expenses attributable to recent acquisitions 
as a percentage of revenues  general and administrative expenses decreased to approximately from approximately primarily due to the significant increase in revenues 
amortization of intangible assets was  in as compared to  in this increase was attributable to the company s acquisitions of new business services agreements in the first quarter of and the second and third quarters of this increase was partially offset by the elimination of amortization of exclusive rights associated with certain single physician reproductive science centers 
impairment losses were recorded in the second quarter of to writeoff unamortized exclusive rights payments on these reproductive science centers 
interest income for decreased to  from  for  due to a lower invested cash balance 
interest expense for increased to  from  in  due to increases in bank borrowings principally to finance working capital needs and in notes payable to medical providers for exclusive rights 
the provision for income taxes  which primarily reflected various state income taxes  increased to  in from  in primarily due to the fact that the last of the new jersey state net operating loss carryforwards were used in and to incremental state taxes related to the fci and shady grove reproductive science centers which were acquired in august and march  respectively 
restructuring and other charges were approximately million for such charges included approximately million associated with the company s termination of its agreement with the reproductive science center of greater philadelphia  a single physician reproductive science center  effective july   which primarily consisted of exclusive right impairment and other asset write offs 
such charges also included approximately  for exclusive right impairment losses related to two other single physician reproductive science centers 
the latter impairment losses were recorded based upon the company s determination that the intangible asset balance was larger than the respective medical practice s estimated future cashflow 
income from continuing operations excluding restructuring and other charges was approximately million for as compared to  for the increase was primarily due to the approximate million increase in reproductive science center contribution  which was partially offset by increases in general and administrative expenses  amortization of intangible assets  interest and income tax expense 
effective september   the company disposed of the awm division operations via a sale of certain of its fixed assets to a third party and the third party s assumption of the employees  building lease  research contracts  and medical records 
this disposal was classified as a discontinued operation for which an aggregate charge of approximately million was recorded in  of which  represented loss from operations and approximately million represented loss from the disposal of the awm division 
the loss from disposal of the awm division principally represented approximately million related to the write off of goodwill and  for estimated operating losses during june through september   the phase out period 
during the eight month period ended august  and the year ended december   the awm division recorded revenues of approximately million and million  respectively  which are classified as discontinued operations 
revenues  net for were approximately million as compared to approximately million for  an increase of approximately million  or 
the increase in revenues was attributable to new business services agreements entered into in each of the first three quarters of  partially offset by the absence of revenue related to the westchester and east long meadow  ma reproductive science center agreements which were terminated in november and january  respectively 
the aggregate increase in revenue was comprised of the following i an approximate million increase in reimbursed costs of services  and ii an approximate million increase in the company s business services fees derived from the managed medical practices net revenue and or earnings 
liquidity and capital resources historically  the company has financed its operations primarily through sales of equity securities 
more recently  the company has commenced using bank financing for working capital and acquisition purposes 
the company anticipates that its acquisition strategy will continue to require substantial capital investment 
capital is needed not only for additional acquisitions  but also for the effective integration  operation and expansion of the company s existing reproductive science centers 
the medical practices may require capital for renovation and expansion and for the addition of medical equipment and technology 
as of december   the company had working capital of approximately million  compared to million in the net decrease in working capital was primarily due to fixed asset and leasehold improvement purchases of million  debt repayments of million and the repurchase of approximately  shares of common stock for an aggregate purchase price of million 
in september  the company obtained from fleet bank  na fleet a million credit facility the new credit facility 
the new credit facility is comprised of a million three year working capital revolver  a million three year acquisition revolver and a million year term loan 
upon closing of the new credit facility  the company drew the entire million available under the term loan to repay in full its balance outstanding with first union national bank of  and for working capital purposes as well as common stock repurchases 
availability of borrowings under the working capital revolver are based on eligible accounts receivable as defined 
availability of borrowings under the acquisition revolver will be based on financial covenants and eligibility criteria with respect to each proposed acquisition 
as of december   under the working capital and acquisition revolvers  there were no amounts outstanding and an aggregate amount of approximately million was available  exclusive of additional amounts  which may become available as a result of completing additional acquisitions 
the company does not have any significant commitments for the acquisition of fixed assets 
year issue in prior years  the company discussed the nature and progress of its plans to become year ready 
in late  the company completed its remediation and testing of its software and hardware systems 
as a result of those planning and implementation efforts  the company experienced no significant disruptions in mission critical information technology and non information technology systems and believes those systems successfully responded to the year date change 
the company expensed approximately  during in connection with remediating its systems 
the company is not aware of any material problems resulting from year issues  either with its products  its internal systems  or the products and services of third parties 
the company will continue to monitor its mission critical computer applications and those of its suppliers and vendors throughout the year to ensure that any latent year matters that may arise are addressed promptly 
new accounting standards in december  the securities and exchange commission issued staff accounting bulletin number  revenue recognition in financial statements  summarizing the staff s views in applying generally accepted accounting principles to revenue recognition in financial statements 
although the company believes it is in compliance with this guidance in all material respects  the company is currently evaluating its current revenue recognition policies to determine the impact of the staff accounting bulletin  if any 
forward looking statements this form k and discussions and or announcements made by or on behalf of the company  contain certain forward looking statements regarding events and or anticipated results within the meaning of the safe harbor provisions of the private securities litigation reform act of  the attainment of which involve various risks and uncertainties 
forward looking statements may be identified by the use of forward looking terminology such as  may  will  expect  believe  estimate  anticipate  continue  or similar terms  variations of those terms or the negative of those terms 
the company s actual results may differ materially from those described in these forward looking statements due to the following factors the company s ability to acquire additional business services agreements  including the company s ability to raise additional debt and or equity capital to finance future growth  the loss of significant business services agreement s  the profitability or lack thereof at reproductive science centers serviced by the company  the company s ability to transition sole practitioners to group practices  increases in overhead due to expansion  the exclusion of infertility and art services from insurance coverage  government laws and regulation regarding health care  changes in managed care contracting  the timely development of and acceptance of new infertility  and art and or genetic technologies and techniques 
item a 
quantitative and qualitative disclosures about market risk not applicable 

